Predicting Survival in Patients with Malignant Pleural Mesothelioma
|

Predicting Survival in Patients with Malignant Pleural Mesothelioma

Researchers found a new way of predicting survival in malignant pleural mesothelioma patients. The prognostic model takes information from the health record to predict survival. Mesothelioma is a rare form of cancer caused by exposure to asbestos. The new prognostic model can help doctors decide on the best treatment plan. This is important for newly-diagnosed patients. And it will have a big impact on their prognosis and quality of life. Many factors can affect a malignant mesothelioma prognosis. Some relate to the patient’s overall health and disease stage or type. While others have to do with the type of treatment the patient undergoes. Several prognostic models have been developed for mesothelioma. These all include information from the patient’s record. And…

Understanding the New Multimodality Prognostic Score (MMPS) in Mesothelioma

Understanding the New Multimodality Prognostic Score (MMPS) in Mesothelioma

The Multimodality Prognostic Score (MMPS) is a new tool for evidence-based mesothelioma treatment. It has given clinicians and surgeons a new guideline in multimodality treatment. The treatment options for mesothelioma are many. Often, one treatment alone cannot control cancer so many treatment types are required. Multimodal therapy can be tailored to each patient’s case. The Multimodality Prognostic Score (MMPS) has an update. It is a tool in the clinician’s toolbox for outlining a treatment plan. Surgical Options Surgery is a common treatment option for malignant pleural mesothelioma. There are two surgeries that are most common. The first is pleurectomy and decortication (P/D) surgery. The second is an extrapleural pneumonectomy (EPP). Pleurectomy and decortication surgery (P/D) is a common pleural mesothelioma…